X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-11-13 | ARDX | Mott David M | Dir | P - Purchase | $4.62 | +215,868 | 1,425,465 | +18% | +$996,598 | ||||||
2024-11-11 | ARDX | Raab Michael | Pres, CEO | S - Sale | $4.90 | -2,743 | 1,232,729 | 0% | -$13,441 | ||||||
| D | 2024-11-06 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale+OE | $6.10 | -27,171 | 533,154 | -5% | -$165,743 | |||||
| D | 2024-11-04 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale+OE | $5.95 | -27,172 | 533,154 | -5% | -$161,673 | |||||
| D | 2024-10-28 | ARDX | Raab Michael | Pres, CEO | S - Sale+OE | $5.91 | -25,000 | 1,235,472 | -2% | -$147,740 | |||||
2024-10-11 | ARDX | Raab Michael | Pres, CEO | S - Sale | $6.01 | -7,500 | 1,235,472 | -1% | -$45,075 | ||||||
2024-09-27 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $6.92 | -49,564 | 533,154 | -9% | -$342,983 | ||||||
2024-09-26 | ARDX | Raab Michael | Pres, CEO | S - Sale | $6.07 | -3,000 | 1,242,972 | 0% | -$18,210 | ||||||
2024-09-13 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $6.26 | -5,312 | 582,718 | -1% | -$33,254 | ||||||
| D | 2024-09-11 | ARDX | Raab Michael | Pres, CEO | S - Sale+OE | $5.61 | -35,000 | 1,245,972 | -3% | -$196,399 | |||||
2024-08-27 | ARDX | Raab Michael | Pres, CEO | S - Sale | $6.22 | -7,500 | 1,244,873 | -1% | -$46,635 | ||||||
2024-08-20 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $5.86 | -7,412 | 314,740 | -2% | -$43,437 | ||||||
2024-08-20 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $5.86 | -7,219 | 585,354 | -1% | -$42,306 | ||||||
2024-08-20 | ARDX | Renz Justin A | CFO | S - Sale | $5.86 | -5,289 | 295,257 | -2% | -$30,995 | ||||||
2024-08-20 | ARDX | Raab Michael | Pres, CEO | S - Sale | $5.86 | -32,225 | 1,252,373 | -3% | -$188,848 | ||||||
2024-08-20 | ARDX | Grammer Elizabeth A | See Remarks | S - Sale | $5.86 | -7,089 | 192,380 | -4% | -$41,544 | ||||||
2024-08-20 | ARDX | Felsch Robert Ora | See Remarks | S - Sale | $5.86 | -3,567 | 91,560 | -4% | -$20,904 | ||||||
2024-08-20 | ARDX | Blanks Robert | See Remarks | S - Sale | $5.86 | -4,969 | 319,362 | -2% | -$29,120 | ||||||
| DM | 2024-08-16 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale+OE | $5.97 | -40,507 | 592,573 | -6% | -$241,782 | |||||
2024-08-12 | ARDX | Raab Michael | Pres, CEO | S - Sale | $5.71 | -1,229 | 1,284,598 | 0% | -$7,018 | ||||||
| D | 2024-07-29 | ARDX | Raab Michael | Pres, CEO | S - Sale+OE | $5.64 | -30,000 | 1,285,827 | -2% | -$169,314 | |||||
2024-07-15 | ARDX | Raab Michael | Pres, CEO | S - Sale | $5.97 | -7,500 | 1,285,827 | -1% | -$44,768 | ||||||
2024-06-28 | ARDX | Raab Michael | Pres, CEO | S - Sale | $6.59 | -2,310 | 1,293,327 | 0% | -$15,223 | ||||||
2024-06-21 | ARDX | Blanks Robert | See Remarks | S - Sale | $5.96 | -38,000 | 324,331 | -10% | -$226,290 | ||||||
| D | 2024-06-13 | ARDX | Raab Michael | Pres, CEO | S - Sale+OE | $6.65 | -35,000 | 1,295,637 | -3% | -$232,743 | |||||
| D | 2024-06-05 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale+OE | $7.12 | -145,000 | 322,152 | -31% | -$1,033,080 | |||||
2024-06-03 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $7.00 | -17,872 | 612,573 | -3% | -$125,104 | ||||||
2024-05-29 | ARDX | Raab Michael | Pres, CEO | S - Sale | $6.72 | -7,500 | 1,295,637 | -1% | -$50,390 | ||||||
2024-05-21 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $7.81 | -4,794 | 367,152 | -1% | -$37,446 | ||||||
2024-05-21 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $7.81 | -7,053 | 630,445 | -1% | -$55,091 | ||||||
2024-05-21 | ARDX | Rodriguez Susan | Chief Commercial Officer | S - Sale | $7.81 | -6,703 | 449,092 | -1% | -$52,357 | ||||||
2024-05-21 | ARDX | Renz Justin A | CFO | S - Sale | $7.81 | -5,167 | 300,546 | -2% | -$40,359 | ||||||
2024-05-21 | ARDX | Raab Michael | Pres, CEO | S - Sale | $7.81 | -31,484 | 1,303,137 | -2% | -$245,922 | ||||||
2024-05-21 | ARDX | Grammer Elizabeth A | See Remarks | S - Sale | $7.81 | -6,927 | 199,469 | -3% | -$54,107 | ||||||
2024-05-21 | ARDX | Felsch Robert Ora | See Remarks | S - Sale | $7.81 | -3,485 | 95,127 | -4% | -$27,221 | ||||||
2024-05-21 | ARDX | Blanks Robert | See Remarks | S - Sale | $7.81 | -4,855 | 362,331 | -1% | -$37,922 | ||||||
2024-05-14 | ARDX | Raab Michael | Pres, CEO | S - Sale | $7.99 | -3,000 | 1,333,297 | 0% | -$23,970 | ||||||
| D | 2024-05-06 | ARDX | Felsch Robert Ora | See Remarks | S - Sale+OE | $8.81 | -207,988 | 95,947 | -68% | -$1,831,503 | |||||
| D | 2024-05-06 | ARDX | Grammer Elizabeth A | See Remarks | S - Sale+OE | $8.88 | -284,170 | 203,760 | -58% | -$2,522,217 | |||||
2024-05-03 | ARDX | Grammer Elizabeth A | See Remarks | S - Sale | $9.00 | -45,000 | 267,993 | -14% | -$405,000 | ||||||
| D | 2024-05-03 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale+OE | $8.35 | -39,949 | 370,189 | -10% | -$333,574 | |||||
| D | 2024-04-29 | ARDX | Raab Michael | Pres, CEO | S - Sale+OE | $6.40 | -30,000 | 1,336,297 | -2% | -$192,057 | |||||
2024-04-15 | ARDX | Raab Michael | Pres, CEO | S - Sale | $7.06 | -7,500 | 1,336,297 | -1% | -$52,924 | ||||||
2024-04-01 | ARDX | Raab Michael | Pres, CEO | S - Sale | $7.31 | -1,518 | 1,343,797 | 0% | -$11,097 | ||||||
2024-03-20 | ARDX | Grammer Elizabeth A | See Remarks | S - Sale | $7.73 | -86,000 | 312,993 | -22% | -$664,978 | ||||||
2024-02-26 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $9.20 | -5,183 | 632,513 | -1% | -$47,684 | ||||||
2024-02-20 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $8.75 | -7,311 | 637,696 | -1% | -$63,944 | ||||||
2024-02-20 | ARDX | Renz Justin A | CFO | S - Sale | $8.75 | -5,341 | 304,835 | -2% | -$46,714 | ||||||
2024-02-20 | ARDX | Raab Michael | Pres, CEO | S - Sale | $8.75 | -22,917 | 1,345,315 | -2% | -$200,439 | ||||||
2024-02-20 | ARDX | Blanks Robert | See Remarks | S - Sale | $8.75 | -5,017 | 368,186 | -1% | -$43,880 | ||||||
2024-02-20 | ARDX | Grammer Elizabeth A | See Remarks | S - Sale | $8.75 | -4,432 | 398,993 | -1% | -$38,764 | ||||||
2024-02-20 | ARDX | Rodriguez Susan | Chief Commercial Officer | S - Sale | $8.75 | -6,928 | 452,795 | -2% | -$60,594 | ||||||
2024-02-20 | ARDX | Felsch Robert Ora | See Remarks | S - Sale | $8.75 | -2,352 | 184,834 | -1% | -$20,571 | ||||||
2024-02-20 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $8.75 | -4,803 | 380,138 | -1% | -$42,008 | ||||||
2024-02-08 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $9.18 | -15,344 | 645,007 | -2% | -$140,846 | ||||||
2024-01-08 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $6.64 | -30,000 | 477,481 | -6% | -$199,200 | ||||||
| D | 2023-12-26 | ARDX | Renz Justin A | CFO | S - Sale+OE | $6.36 | -225,000 | 182,426 | -55% | -$1,430,123 | |||||
2023-12-18 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $6.07 | -5,675 | 507,481 | -1% | -$34,447 | ||||||
2023-12-14 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $5.55 | -7,000 | 513,156 | -1% | -$38,850 | ||||||
2023-12-11 | ARDX | Grammer Elizabeth A | See Remarks | S - Sale | $5.08 | -50,000 | 275,675 | -15% | -$253,925 | ||||||
2023-12-08 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $5.27 | -20,000 | 520,156 | -4% | -$105,476 | ||||||
2023-12-05 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $5.00 | -10,272 | 540,156 | -2% | -$51,360 | ||||||
2023-11-30 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $4.50 | -3,000 | 550,428 | -1% | -$13,500 | ||||||
2023-11-20 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $4.36 | -2,581 | 266,191 | -1% | -$11,259 | ||||||
2023-11-20 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $4.36 | -3,767 | 553,428 | -1% | -$16,432 | ||||||
2023-11-20 | ARDX | Rodriguez Susan | Chief Commercial Officer | S - Sale | $4.36 | -4,714 | 346,973 | -1% | -$20,563 | ||||||
2023-11-20 | ARDX | Renz Justin A | CFO | S - Sale | $4.36 | -2,873 | 332,426 | -1% | -$12,533 | ||||||
2023-11-20 | ARDX | Raab Michael | Pres, CEO | S - Sale | $4.36 | -11,368 | 893,232 | -1% | -$49,589 | ||||||
2023-11-20 | ARDX | Grammer Elizabeth A | See Remarks | S - Sale | $4.36 | -2,384 | 325,675 | -1% | -$10,399 | ||||||
2023-11-20 | ARDX | Felsch Robert Ora | See Remarks | S - Sale | $4.36 | -1,044 | 117,066 | -1% | -$4,554 | ||||||
2023-11-20 | ARDX | Blanks Robert | See Remarks | S - Sale | $4.36 | -2,835 | 260,453 | -1% | -$12,367 | ||||||
2023-11-15 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $4.00 | -25,000 | 266,839 | -9% | -$99,998 | ||||||
2023-10-10 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $4.00 | -1,644 | 557,195 | 0% | -$6,576 | ||||||
2023-09-08 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $4.55 | -2,897 | 558,839 | -1% | -$13,181 | ||||||
2023-08-21 | ARDX | Rodriguez Susan | Chief Commercial Officer | S - Sale | $3.55 | -4,733 | 348,687 | -1% | -$16,811 | ||||||
2023-08-21 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $3.55 | -2,591 | 291,839 | -1% | -$9,203 | ||||||
2023-08-21 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $3.55 | -3,783 | 558,736 | -1% | -$13,436 | ||||||
2023-08-21 | ARDX | Renz Justin A | CFO | S - Sale | $3.55 | -2,884 | 333,849 | -1% | -$10,243 | ||||||
2023-08-21 | ARDX | Raab Michael | Pres, CEO | S - Sale | $3.55 | -11,419 | 901,600 | -1% | -$40,558 | ||||||
2023-08-21 | ARDX | Grammer Elizabeth A | See Remarks | S - Sale | $3.55 | -2,392 | 328,059 | -1% | -$8,496 | ||||||
2023-08-21 | ARDX | Felsch Robert Ora | See Remarks | S - Sale | $3.55 | -1,048 | 115,110 | -1% | -$3,722 | ||||||
2023-08-21 | ARDX | Blanks Robert | See Remarks | S - Sale | $3.55 | -2,846 | 263,288 | -1% | -$10,108 | ||||||
2023-06-27 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $3.35 | -25,000 | 294,430 | -8% | -$83,633 | ||||||
| D | 2023-06-23 | ARDX | Blanks Robert | See Remarks | S - Sale+OE | $3.63 | -33,333 | 266,134 | -11% | -$121,042 | |||||
2023-05-23 | ARDX | Felsch Robert Ora | See Remarks | S - Sale | $3.65 | -1,046 | 116,158 | -1% | -$3,821 | ||||||
2023-05-23 | ARDX | Raab Michael | Pres, CEO | S - Sale | $3.65 | -11,357 | 913,019 | -1% | -$41,489 | ||||||
2023-05-23 | ARDX | Grammer Elizabeth A | See Remarks | S - Sale | $3.65 | -2,384 | 330,451 | -1% | -$8,709 | ||||||
2023-05-23 | ARDX | Blanks Robert | See Remarks | S - Sale | $3.65 | -2,835 | 266,134 | -1% | -$10,357 | ||||||
2023-05-23 | ARDX | Renz Justin A | CFO | S - Sale | $3.65 | -2,873 | 336,733 | -1% | -$10,496 | ||||||
2023-05-23 | ARDX | Rodriguez Susan | Chief Commercial Officer | S - Sale | $3.65 | -4,711 | 353,420 | -1% | -$17,210 | ||||||
2023-05-23 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $3.65 | -3,769 | 562,519 | -1% | -$13,769 | ||||||
2023-05-23 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $3.65 | -2,583 | 319,430 | -1% | -$9,436 | ||||||
2023-03-29 | ARDX | Rosenbaum David P. | Chief Development Officer | S - Sale | $4.63 | -3,000 | 566,288 | -1% | -$13,888 | ||||||
2023-02-21 | ARDX | Rodriguez Susan | Chief Commercial Officer | S - Sale | $3.00 | -5,586 | 355,131 | -2% | -$16,764 | ||||||
2023-02-21 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $3.00 | -3,187 | 319,013 | -1% | -$9,564 | ||||||
2023-02-21 | ARDX | Blanks Robert | See Remarks | S - Sale | $3.00 | -3,394 | 268,969 | -1% | -$10,185 | ||||||
2023-02-21 | ARDX | Grammer Elizabeth A | See Remarks | S - Sale | $3.00 | -2,914 | 332,925 | -1% | -$8,745 | ||||||
2023-02-21 | ARDX | Raab Michael | Pres, CEO | S - Sale | $3.00 | -13,449 | 921,376 | -1% | -$40,360 | ||||||
2023-02-21 | ARDX | Felsch Robert Ora | See Remarks | S - Sale | $3.00 | -3,214 | 114,204 | -3% | -$9,645 | ||||||
2023-02-21 | ARDX | Renz Justin A | CFO | S - Sale | $3.00 | -3,439 | 336,606 | -1% | -$10,320 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |